ECH1 and congenital bilateral aplasia of vas deferens from CFTR mutation: Therefore, our study provides novel insights into the molecular mechanism regulating Wnt5a/Ca2+ in the pathogenesis of CAVD, targeting ECH1 may prove of therapeutic potential to aortic valve calcification.